Among them, leptin and adiponectin are two extensively investigated ones that are intricately linked with the development and progression of NAFLD (Imajo et al., 2012; Marra & Bertolani, 2009). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.